AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-100057251/ssp-japan-1st-otc.html" title="Facts and information about SSP: Japan's 1st OTC drug for sleep disorder, Drewel.">SSP: Japan's 1st OTC drug for sleep disorder, Drewel.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
SSP: Japan's 1st OTC drug for sleep disorder, Drewel.
(From Chemical Business NewsBase - Pharma Japan)
SSP, after more than 12 years development, will launch an over-the-counter drug called Drewel that contains diphenhydramine HCI, a drug for the control of sleep disorder. Although insomnia treatments are widely …
Related articles from newspapers, magazines, journals, and more
-
- Alfresa obtains approval for narcolepsy treatment.
-
News wire article from: Chemical Business Newsbase
February 5, 2007
700+ words
-
- Rozerem could reach US market in September 2005 at earlier: Takeda.
-
News wire article from: Asia Africa Intelligence Wire
July 25, 2005
700+ words
